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In the dark ages of T cell biology, we considered two fates for differentiated 
CD4+ T cells: T helper (Th)1 and Th2 cells. Now we know that the reality is 
much more complex and interesting. The newest Th cell subset produces the 
cytokine IL-17. New evidence shows that the IL-17–related cytokine IL-25 is 
essential for Th2 responses in two infectious disease models. 
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In this commentary, we will consider 
the new information pertaining to IL-25 
in the context of the emerging under-
standing of the regulation and action of 
other IL-17 family members. We will 
also discuss how these new insights 
change our concept of Th cell diff  eren-
tiation and immunoregulation in host 
defense and immune-mediated disease.
Cytokines driving Th cell differentiation
The Th1/Th2 cell dichotomy and the 
essential role of the cytokine environ-
ment in driving their diff  erentiation are 
well accepted. Interleukin (IL)-12, act-
ing via the transcription factors Stat4 and 
T-bet, drives the diff  erentiation of naive 
CD4+ T cells into interferon (IFN)-
γ–producing Th1 cells, whereas IL-4, 
acting via Stat6 and GATA3, drives the 
diff  erentiation of IL-4–producing Th2 
cells. Numerous infectious models sup-
port the notion that Th1 and Th2 cells 
act independently. Th1 cells are respon-
sible for the cell-mediated elimination 
of intracellular pathogens, whereas erad-
ication of helminthic infestations is de-
pendent on adequate Th2 responses. 
However, the immunopathogenesis of 
autoimmune disease does not fi  t quite 
so neatly into this dichotomy. CD4+ 
T cells can also diff  erentiate into cells 
that produce the immunosuppressive 
cytokines IL-10 and TGFβ, so-called 
Th3 cells, and can become “adaptive” 
regulatory T cells. Both cell types appear 
to protect against autoimmunity. Studies 
of experimental autoimmune encepha-
lophalomyelitis and adjuvant-induced 
arthritis have pointed to the importance 
of yet another Th cell subset, which 
produces IL-17 and is now termed Th17 
cells. Although this population of T cells 
has been implicated in the exacerbation 
of autoimmune pathology (1–3), the 
role of Th17 cells in host defense  remains 
to be elucidated.
The IL-17 family
The subject of two papers in the issue 
(Owyang et al., p. 843 [4] and Fallon 
et al., p. 1105 [5]) is the Th2-like cyto-
kine, IL-25, which as a member of the 
IL-17 family is also known as IL-17E. 
Structurally, this family of six cytokines 
(IL-17A-F) is thought to form cystine 
knots and in this respect is related to 
other better known cytokines such as 
TGFβ and platelet-derived growth 
  factor. IL-17 (IL-17A) was originally 
reported to be produced mainly by 
  eff  ector and memory CD4+ T cell sub-
sets, but has more recently been sugg-
ested to be more widely expressed (6, 7). 
IL-17F is located adjacent to IL-17 
on mouse chromosome 1 (human chro-
mosome 6), and although it seems to be 
regulated in a similar manner, it may be 
more widely expressed than IL-17. Less 
well studied are IL-17B, IL-17C, and 
IL-17D, which are thought to be ex-
pressed in a variety of nonhematopoe-
itic tissues, although IL-17D is reported 
to be produced by CD4+ T cells (8). 
Five IL-17 receptors have been identi-
fi  ed, but only the receptors for IL-17/
IL-17F and IL-25 have been character-
ized. The IL-17 receptor is structurally 
distinct from other cytokine receptors, 
and engagement of the receptor acti-
vates MAP kinases and NF-κB. Signal-
ing via IL-25 is reported to be dependent 
on the adaptor molecule TRAF6 (9).
With respect to their biological ac-
tions, IL-17 and IL-17F are most inten-
sively studied. These cytokines evoke 
infl   ammation largely by inducing the 
production of chemokines, as well as 
granulocyte colony-stimulating factor 
and granulocyte macrophage colony-
stimulating factor, with the subsequent 
recruitment of polymorphonuclear 
  leukocytes. In some settings, however, 
IL-17– or IL-17F–induced infl  amma-
tion is dominated by macrophages (10). 
The induction of matrix metallopro-
teinase production by epithelial cells 
may be another important proinfl  am-
matory function of IL-17 (11). Abun-
dant data point to pathogenic roles of 
IL-17 in models of immune-mediated 
disease and in human autoimmune dis-
orders. Less well defi  ned are the benefi  -
cial roles of IL-17 family cytokines in 
host defense, although recent data indi-
cate IL-17 is important for resistance 
against Klebsiella pneumoniae and Myco-
bacterium tuberculosis (12–14).
Unlike IL-17 and IL-17F, IL-25 is 
produced by Th2 cells and mast cells 
(15). Administration of recombinant 
IL-25 (rIL-25) to mice has been shown 
to evoke an infl  ammatory  response 
characterized by the overproduction 
of Th2 cytokines, hyperproduction of 
  immunoglobulins IgA and IgE, over-
production of mucus, epithelial cell 
  hyperplasia, and eosinophilia. Further-
more, the observed pathology was 
  dependent on the classical Th2 cyto-
kines IL-4 and IL-13, as shown by the 
lack of eff  ect of administering rIL-25 to 
mice that lack these cytokines or their 
cognate receptor.810  NEW INSIGHTS IN T CELL DIFFERENTIATION | Tato et al.
The Th17 lineage
Th17 cells are now thought to be a sep-
arate lineage of eff  ector Th cells, but 
the optimal recipe to diff  erentiate Th17 
cells in vitro remains somewhat unclear 
(10, 16–18), and the in vivo require-
ments for their diff  erentiation have yet 
to be fi  rmly established. Several groups 
have pointed to the importance of IL-23 
as a critical ingredient for the genera-
tion and/or maintenance of this lineage 
(10, 13, 17–20). It should be kept in 
mind that because of its structural simi-
larity to IL-12 (p35/p40) (21–24) IL-23 
(p19/p40) also has the potential to in-
duce a Th1-like response. Recently, 
another group has come up with a dif-
ferent recipe to make Th17 cells that 
involves a milieu of cytokines produced 
by lipopolysaccharide-activated dendritic 
cells (namely IL-1, IL-6, and TNF-α) 
and the presence of TGFβ (25). These 
fi   ndings not only illustrate that there 
is  overlap in the groups of cytokines 
that induce diff   erent populations of 
CD4+ T cells, but also emphasize 
that a particular cytokine, in this case 
TGFβ, may have both   proinfl  ammatory 
(Th17-inducing) and antiinfl  ammatory 
(Th3-inducing) roles, depending on 
the circumstances.
Roles for IL-25 in host defense 
and controlling infl  ammation
In this issue, two new studies by Owy-
ang et al. (4) and Fallon et al. (5) show 
that IL-25−/− mice have increased sus-
ceptibility to the parasitic helminthes, 
Trichuris muris, and Nippostrongylus 
brasiliensis. Both groups found that the 
antihelminth activity of IL-25 depends 
on its ability to induce the Th2-associ-
ated cytokines IL-4, IL-5, and IL-13. 
In the case of T. muris infection, the 
susceptibility of IL-25−/− mice was as-
sociated with impaired IL-4 and IL-13 
production and reduced Trichuris-spe-
cifi  c IgG1 and total IgE. In addition, 
chronically infected IL-25−/− mice had 
exacerbated pathology, which was 
characterized by severe infl  ammation 
and disruption of intestinal epithelial 
structure, and was associated with in-
creased production of IFN-γ, IL-17, 
and total IgG2a. Thus, in addition to an 
essential role in driving antihelminth 
Th2 responses, this study implies an 
  antiinfl  ammatory role for IL-25 in sup-
pressing Th1 and Th17 responses. In 
contrast, Fallon et al. (5) found that 
IL-25 was not absolutely required for 
the generation of Th2 responses in 
N. brasiliensis infection, but that IL-25 
was important for the timely resolution 
of the infection. When IL-25−/− mice 
were challenged with N. brasiliensis, the 
polarization of the Th2 response, mani-
fested as enhanced IL-4, IL-5, and 
IL-13 production, was delayed. This re-
sulted in slower elimination of worms 
and delayed IgE production. Interest-
ingly, blockade of Th1 responses with 
anti–IL-12 and anti–IFN-γ antibodies 
reduced the worm burden and en-
hanced Th2 responses in Trichuris-in-
fected IL-25−/− mice, as well as in the 
naturally susceptible AKR mouse strain. 
Thus, IL-25 does not appear to be ab-
solutely essential for Th2 responses to 
some helminthes, and may promote 
host defense by inhibiting expression of 
type 1 cytokines.
Which cell types produce IL-25 and 
which cell types respond to it? Using 
mice that have the reporter lacZ knocked 
into the IL-25 locus, Owyang et al. (4) 
found that IL-25 expression is, in fact, 
very limited. It was constitutively ex-
pressed by CD4+ and CD8+ T cells in 
the gut but was not expressed in a vari-
ety of innate immune cells. These data 
hint at the possible existence of eff  ector 
T cells that selectively produce IL-25 
(a putative Th25 lineage), which may play 
a specifi  c role in mucosal immunity. In 
their study, Fallon et al. (5) report that 
the target of IL-25 is a nonlymphoid 
c-kit+ cell present in the draining lymph 
node. The fi  nding that the IL-25–medi-
ated expulsion of N. brasiliensis was T 
and B cell independent emphasizes the 
importance of this nonlymphoid popu-
lation. Using mice in which the reporter 
eGFP was knocked into the IL-4 locus, 
Fallon et al. (5) show that nonlymphoid 
c-kit+ cells are major producers of IL-4 
during infection and their appearance in 
the draining lymph node precedes the 
expansion of IL-4–producing CD4+ 
cells. These fi  ndings are consistent with 
previous work using rIL-25, which in-
dicated that this cytokine does not have 
direct eff  ects on diff  erentiating T cells, 
but rather that its action requires non-
lymphoid cells.
New fi  ndings, new questions
As all good studies should, these two 
papers raise more questions than they 
answer (4, 5). Together they suggest a 
new conceptual framework for Th2 cell 
diff  erentiation. The fi  ndings are of con-
siderable interest because, compared to 
the seemingly clear cut mechanisms in-
volved in Th1 cell diff  erentiation, the 
factors that drive Th2 cell diff  erentia-
tion have been more diffi   cult to under-
stand. Both groups convincingly show 
that IL-25 is an important regulator 
of  Th2 responses and host defense. 
Whether IL-25 is produced by T cells 
for T cells or by APCs for nonlymphoid 
eff   ector populations it indisputably 
serves to enhance IL-4 production re-
sulting in amplifi  cation of Th2-  mediated 
immunity. These reports also indi-
cate  that IL-25 controls infl  ammation 
during helminth infection and dampens 
counterproductive Th1 responses, in-
dependent of IL-25’s eff  ects on Th2 
cell diff   erentiation. The duality of 
IL-25 activity mirrors that of the well-
known immunosuppressive cytokine 
TGFβ, which, as mentioned, induces 
the polarization of proinfl  ammatory 
Th17 cells (25).
The paradigm of Th1 and Th2 
  responses is fi   rmly supported by an 
  immense amount of in vitro data but, 
more importantly, is substantiated in 
many infectious disease models and 
some autoimmune disease models. As 
the papers in this issue exemplify (4, 5), 
the generation of other T cell subsets 
in models of host defense is less clear 
cut (Fig. 1). IFN-γ promotes Th1 cell 
  diff  erentiation by inducing T-bet, but 
inhibits both Th17 cell and Th2 cell 
diff  erentiation (26, 27). Similarly, IL-4, 
by inducing GATA-3, inhibits Th17 
cell and Th1 cell diff  erentiation. Thus, 
it would appear that the generation of 
Th1, Th2, and Th17 cells is carefully 
balanced. In contrast to the well-
  described positive eff  ects of IFN-γ and 
IL-4 on their respective lineages, no data 
have been provided indicating that IL-17 
directly regulates Th cell diff  erentiation, COMMENTARY
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either positively or negatively (27, 28). 
Furthermore, will we fi  nd that like Th1 
and Th17 cells, IL-25–secreting cells 
are really a distinct lineage from Th2 
cells and subject to diff  erent  modes 
of regulation? To this end, the question 
of whether the putative Th25 cell 
  population expresses lineage-specifi  c 
transcription factors that determine its 
cytokine production profi  le will likely 
be a focus of future studies. Further 
studies are also needed to understand 
and defi  ne the functional role of Th17 
and Th25 cells as either primary eff  ec-
tors similar to Th1 and Th2 cells, or 
sentinel populations that promote or 
enhance more specifi  c  cell-mediated 
immunity in mucosal tissues. One 
might envision a scenario in which 
pleiotropic cytokines such as IL-17, 
TGFβ, and IL-25 not only potentiate 
early Th responses and recruitment of 
cells to lymph nodes and tissues, but 
also regulate aberrant infl  ammatory 
  responses during the resolution of in-
fection. The ability of IL-25 to limit 
Th1-induced infl   ammation might be 
an example of the latter. How all of this 
relates to human health and disease is 
less clear, and with future studies re-
fi  ned concepts of T cell diff  erentiation 
will come to bear.
In conclusion, this is a very exciting 
time for T cell biologists. In the age of 
monarchies, the expression “Le roi est 
mort; vive le roi” marked the passing 
of eras, ushering out one regime while 
introducing another. Analogously, it 
might be said, “T cell diff  erentiation is 
dead; long live T cell diff  erentiation.” 
Suddenly, understanding the molecular 
regulation of T cell diff  erentiation has 
become much more complicated. The 
simple notion of a dualistic view of Th1/
Th2 cell diff  erentiation is moribund, but 
the era of new complexities of immu-
noregulation promises to provide better 
understanding of mechanisms of host 
defense and immune-mediated disease.
The authors thank Richard Siegel, Zhi Chen, and Wendy 
Watford for helpful discussions.
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